Synthesis 2014; 46(13): 1751-1756
DOI: 10.1055/s-0033-1341104
paper
© Georg Thieme Verlag Stuttgart · New York

A New Enantioselective Synthesis of the Anti-Parkinson Agent Safinamide

Anjaneyulu Reddi
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   eMail: m.muthukrishnan@ncl.res.in
,
Mohammad Mujahid
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   eMail: m.muthukrishnan@ncl.res.in
,
Murugesan Sasikumar
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   eMail: m.muthukrishnan@ncl.res.in
,
Murugan Muthukrishnan*
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   eMail: m.muthukrishnan@ncl.res.in
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 13. Januar 2014

Accepted after revision: 13. März 2014

Publikationsdatum:
02. April 2014 (online)


Preview

Abstract

An alternative highly enantioselective synthesis of the anti-Parkinson agent safinamide from simple, commercially available, starting materials is described. The protocol might also be useful in the synthesis of structural variants of safinamide, such as ralfinamide or related analogues

Supporting Information